abstract |
Novel compounds are described having the following formula (I) (see formula (I)) wherein Y is N, O, or S. Pharmaceutical compositions containing the same, methods for treating cancer using the same, and methods for their synthesis. The novel compounds of the present invention are useful for inhibiting protein kinases, especially Chk1 / Chk2 cell cycle regulatory kinases. |